CA
VRTX icon

Commerzbank Aktiengesellschaft’s Vertex Pharmaceuticals VRTX Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.25M Sell
7,281
-810
-10% -$378K 0.07% 113
2025
Q4 		$3.67M Sell
8,091
-484
-6% -$209K 0.07% 115
2025
Q3 		$3.36M Sell
8,575
-1,275
-13% -$533K 0.07% 115
2025
Q2 		$4.39M Buy
9,850
+8,069
+453% +$3.72M 0.1% 89
2025
Q1 		$864K Hold
1,781
– – 0.02% 192
2024
Q4 		$712K Buy
1,781
+509
+40% +$236K 0.02% 183
2024
Q3 		$592K Buy
1,272
+414
+48% +$199K 0.02% 175
2024
Q2 		$403K Buy
858
+71
+9% +$30.8K 0.01% 168
2024
Q1 		$329K Buy
787
+28
+4% +$11.8K 0.01% 194
2023
Q4 		$309K Buy
+759
New +$280K 0.01% 158
2020
Q2 		– Sell
-5,548
Closed -$1.32M – 405
2020
Q1 		$1.32M Sell
5,548
-30,271
-85% -$6.94M 0.06% 154
2019
Q4 		$7.84M Sell
35,819
-172,501
-83% -$34.9M 0.08% 169
2019
Q3 		$35.3M Sell
208,320
-884
-0.4% -$156K 0.27% 75
2019
Q2 		$38.4M Sell
209,204
-49,455
-19% -$8.65M 0.3% 68
2019
Q1 		$47.6M Sell
258,659
-16,017
-6% -$2.96M 0.43% 52
2018
Q4 		$45.5M Buy
274,676
+2,437
+0.9% +$422K 0.47% 49
2018
Q3 		$52.5M Buy
272,239
+8,946
+3% +$1.59M 0.45% 46
2018
Q2 		$44.7M Buy
263,293
+1,872
+0.7% +$290K 0.42% 50
2018
Q1 		$42.6M Buy
261,421
+4,063
+2% +$664K 0.44% 48
2017
Q4 		$38.6M Buy
257,358
+40,401
+19% +$5.98M 0.44% 48
2017
Q3 		$33M Buy
216,957
+5,665
+3% +$853K 0.43% 50
2017
Q2 		$27.2M Sell
211,292
-14,284
-6% -$1.72M 0.46% 52
2017
Q1 		$24.7M Sell
225,576
-32,681
-13% -$2.88M 0.37% 64
2016
Q4 		$19M Buy
258,257
+9,090
+4% +$740K 0.28% 79
2016
Q3 		$21.7M Buy
249,167
+3,759
+2% +$355K 0.35% 59
2016
Q2 		$21.1K Buy
245,408
+20,958
+9% +$1.81M 0.14% 89
2016
Q1 		$17.8M Sell
224,450
-71,685
-24% -$6.48M 0.15% 97
2015
Q4 		$37.3M Buy
296,135
+4,242
+1% +$512K 0.29% 72
2015
Q3 		$30.4M Sell
291,893
-50,868
-15% -$6.54M 0.23% 76
2015
Q2 		$42.3M Buy
342,761
+18,227
+6% +$2.3M 0.22% 78
2015
Q1 		$38.3M Sell
324,534
-24,205
-7% -$2.9M 0.23% 84
2014
Q4 		$41.4M Sell
348,739
-117,953
-25% -$13.3M 0.26% 73
2014
Q3 		$52.4M Buy
466,692
+151,284
+48% +$14.4M 0.21% 74
2014
Q2 		$29.9M Buy
315,408
+159,302
+102% +$11.2M 0.15% 115
2014
Q1 		$11M Sell
156,106
-11,659
-7% -$923K 0.05% 242
2013
Q4 		$13.3M Sell
167,765
-266,602
-61% -$18.6M 0.06% 210
2013
Q3 		$32.9M Buy
434,367
+374,283
+623% +$29.8M 0.16% 115
2013
Q2 		$4.81M Buy
+60,084
New +$4.42M 0.02% 546

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Commerzbank Aktiengesellschaft's VRTX Position: Q1 2026 in Review

Commerzbank Aktiengesellschaft reduced its Vertex Pharmaceuticals (VRTX) stake by 10% in Q1 2026, selling an estimated $378K and leaving 7,281 shares worth $3.25M. The position accounts for 0.07% of the portfolio, ranked #113.

Commerzbank Aktiengesellschaft first reported a position in VRTX in Q2 2013 and has held it in 38 quarters since. The position peaked at $52.5M in Q3 2018. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Commerzbank Aktiengesellschaft held 7,281 shares of Vertex Pharmaceuticals worth $3.25M as of Q1 2026.
  • Commerzbank Aktiengesellschaft sold 810 Vertex Pharmaceuticals shares in Q1 2026, an estimated $378K.
  • Vertex Pharmaceuticals made up 0.07% of Commerzbank Aktiengesellschaft's portfolio in Q1 2026, its #113 holding.
  • Commerzbank Aktiengesellschaft first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 38 quarters since.
  • Commerzbank Aktiengesellschaft's Vertex Pharmaceuticals position peaked at $52.5M in Q3 2018.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2026, filed 7 May 2026.